Physician profile
Benjamin George
NPI 1720515570
$1,158.86
in general payments reported to CMS, 2019-2025
12 companies · $292 in 2025
The $292 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $229 · 2022: $193 · 2023: $95.13 · 2024: $349 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $736.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $355.54 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $254.69 | 2023-2025 | Takhzyro, Eohilia |
| Blueprint Medicines Corporation | $123.50 | 2023-2024 | Ayvakit |
| Corium, LLC | $86.61 | 2024-2025 | Azstarys |
| Bioxcel Therapeutics, INC. | $78.61 | 2025 | Igalmi |
| Ionis Pharmaceuticals, INC. | $60.67 | 2025 | Dawnzera |
| Ars Pharmaceuticals Operations, INC. | $58.52 | 2025 | Neffy |
| Hikma Pharmaceuticals USA | $34.80 | 2024-2025 | Ryaltris |
| Terumo Medical Corporation | $34.29 | 2022 | |
| Sunovion Pharmaceuticals INC. | $32.36 | 2022 | |
| Paratek Pharmaceuticals, INC. | $22.71 | 2024 | Nuzyra |
| Genentech USA, INC. | $16.56 | 2024 | Xolair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.